Article citationsMore>>

US Food and Drug Administration (2014) FDA Drug Safety Communication: Risk of Next-Morning Impairment after Use of Insomnia Drugs. FDA Requires Lower Recommended Doses for Certain Drugs Containing Zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist).

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top